Encompass Health Co. (NYSE:EHC) Forecasted to Post FY2023 Earnings of $3.07 Per Share

Encompass Health logo

Encompass Health Co. (NYSE:EHC – Get Rating) – Investment analysts at Jefferies Financial Group issued their FY2023 earnings per share estimates for shares of Encompass Health in a note issued to investors on Thursday, February 16th. Jefferies Financial Group analyst B. Tanquilut forecasts that the company will earn $3.07 per share for the year. The consensus estimate for Encompass Health’s current full-year earnings is $3.08 per share.

Several other brokerages also recently commented on EHC. Truist Financial upped their price objective on Encompass Health from $70.00 to $75.00 and gave the company a “buy” rating in a research report on Thursday, February 9th. Deutsche Bank Aktiengesellschaft increased their price target on Encompass Health from $62.00 to $70.00 in a research report on Thursday, February 9th. Mizuho increased their price target on Encompass Health from $65.00 to $69.00 and gave the stock a “buy” rating in a research report on Thursday, February 9th. Raymond James increased their price target on Encompass Health from $65.00 to $72.00 and gave the stock a “strong-buy” rating in a research report on Friday, October 28th. Finally, Stephens reissued an “overweight” rating and set a $70.00 price target on shares of Encompass Health in a research report on Wednesday, February 8th. One analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $69.60.

Encompass Health Stock Performance

Want More Great Investment Ideas?

Shares of Encompass Health stock opened at $62.86 on Monday. The stock’s fifty day moving average is $60.35 and its two-hundred day moving average is $54.94. The company has a market capitalization of $6.27 billion, a PE ratio of 23.28, a price-to-earnings-growth ratio of 1.46 and a beta of 1.02. The company has a quick ratio of 1.21, a current ratio of 1.25 and a debt-to-equity ratio of 1.50. Encompass Health has a 52 week low of $44.33 and a 52 week high of $74.61.

Insider Activity at Encompass Health

In other Encompass Health news, CFO Douglas E. Coltharp sold 17,895 shares of the stock in a transaction dated Friday, February 10th. The stock was sold at an average price of $60.78, for a total value of $1,087,658.10. Following the completion of the sale, the chief financial officer now directly owns 53,097 shares in the company, valued at $3,227,235.66. The transaction was disclosed in a document filed with the SEC, which is available at this link. 2.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Encompass Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Baupost Group LLC MA raised its stake in shares of Encompass Health by 318.9% in the first quarter. Baupost Group LLC MA now owns 3,000,000 shares of the company’s stock worth $213,330,000 after purchasing an additional 2,283,900 shares during the last quarter. Point72 Asset Management LP purchased a new position in shares of Encompass Health in the third quarter worth about $51,692,000. Norges Bank purchased a new position in shares of Encompass Health in the fourth quarter worth about $58,988,000. Massachusetts Financial Services Co. MA raised its stake in shares of Encompass Health by 88.8% in the second quarter. Massachusetts Financial Services Co. MA now owns 1,685,880 shares of the company’s stock worth $94,494,000 after purchasing an additional 792,813 shares during the last quarter. Finally, Junto Capital Management LP acquired a new stake in Encompass Health during the fourth quarter worth about $39,264,000. 96.14% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Company Profile

(Get Rating)

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.

Featured Stories

Earnings History and Estimates for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Encompass Health and related companies with MarketBeat.com’s FREE daily email newsletter.

Similar Posts